Stock Screener · Library
ENVOY MEDICAL, INC. financial statement history
Source-linked financial facts for ENVOY MEDICAL, INC. with exact reported periods, units and filing dates. Historical periods ending 2021–2025.
What this record covers
This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.
Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.
Total assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 426903621 | USD | 2023-04-03 | 2022 / FY | us-gaap:Assets | 10-K · 0001104659-23-040842 |
| As of 2022-12-31 | 2556000 | USD | 2024-04-01 | 2023 / FY | us-gaap:Assets | 10-K · 0001213900-24-028894 |
| As of 2023-12-31 | 8271000 | USD | 2025-03-31 | 2024 / FY | us-gaap:Assets | 10-K · 0001013762-25-004299 |
| As of 2024-12-31 | 11538000 | USD | 2026-03-23 | 2025 / FY | us-gaap:Assets | 10-K · 0001213900-26-032683 |
| As of 2025-12-31 | 8558000 | USD | 2026-03-23 | 2025 / FY | us-gaap:Assets | 10-K · 0001213900-26-032683 |
Current assets
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 863167 | USD | 2023-04-03 | 2022 / FY | us-gaap:AssetsCurrent | 10-K · 0001104659-23-040842 |
| As of 2022-12-31 | 1648000 | USD | 2024-04-01 | 2023 / FY | us-gaap:AssetsCurrent | 10-K · 0001213900-24-028894 |
| As of 2023-12-31 | 7456000 | USD | 2025-03-31 | 2024 / FY | us-gaap:AssetsCurrent | 10-K · 0001013762-25-004299 |
| As of 2024-12-31 | 8896000 | USD | 2026-03-23 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001213900-26-032683 |
| As of 2025-12-31 | 6279000 | USD | 2026-03-23 | 2025 / FY | us-gaap:AssetsCurrent | 10-K · 0001213900-26-032683 |
Cash and cash equivalents
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 149845 | USD | 2023-04-03 | 2022 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001104659-23-040842 |
| As of 2022-12-31 | 183000 | USD | 2024-04-01 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001213900-24-028894 |
| As of 2023-12-31 | 4218000 | USD | 2024-04-01 | 2023 / FY | us-gaap:CashAndCashEquivalentsAtCarryingValue | 10-K · 0001213900-24-028894 |
| As of 2024-12-31 | 5483000 | USD | 2026-03-23 | 2025 / FY | us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | 10-K · 0001213900-26-032683 |
| As of 2025-12-31 | 3739000 | USD | 2026-03-23 | 2025 / FY | us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | 10-K · 0001213900-26-032683 |
Inventory
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2022-12-31 | 1295000 | USD | 2024-04-01 | 2023 / FY | us-gaap:InventoryNet | 10-K · 0001213900-24-028894 |
| As of 2023-12-31 | 1404000 | USD | 2025-03-31 | 2024 / FY | us-gaap:InventoryNet | 10-K · 0001013762-25-004299 |
| As of 2024-12-31 | 1708000 | USD | 2026-03-23 | 2025 / FY | us-gaap:InventoryNet | 10-K · 0001213900-26-032683 |
| As of 2025-12-31 | 1546000 | USD | 2026-03-23 | 2025 / FY | us-gaap:InventoryNet | 10-K · 0001213900-26-032683 |
Property, plant and equipment
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2022-12-31 | 331000 | USD | 2024-04-01 | 2023 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001213900-24-028894 |
| As of 2023-12-31 | 351000 | USD | 2025-03-31 | 2024 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001013762-25-004299 |
| As of 2024-12-31 | 1275000 | USD | 2026-03-23 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001213900-26-032683 |
| As of 2025-12-31 | 1035000 | USD | 2026-03-23 | 2025 / FY | us-gaap:PropertyPlantAndEquipmentNet | 10-K · 0001213900-26-032683 |
Total liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 38617145 | USD | 2023-04-03 | 2022 / FY | us-gaap:Liabilities | 10-K · 0001104659-23-040842 |
| As of 2022-12-31 | 38751000 | USD | 2024-04-01 | 2023 / FY | us-gaap:Liabilities | 10-K · 0001213900-24-028894 |
| As of 2023-12-31 | 10047000 | USD | 2025-03-31 | 2024 / FY | us-gaap:Liabilities | 10-K · 0001013762-25-004299 |
| As of 2024-12-31 | 30380000 | USD | 2026-03-23 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001213900-26-032683 |
| As of 2025-12-31 | 20325000 | USD | 2026-03-23 | 2025 / FY | us-gaap:Liabilities | 10-K · 0001213900-26-032683 |
Current liabilities
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | 2678173 | USD | 2023-04-03 | 2022 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001104659-23-040842 |
| As of 2022-12-31 | 2519000 | USD | 2024-04-01 | 2023 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001213900-24-028894 |
| As of 2023-12-31 | 7285000 | USD | 2025-03-31 | 2024 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001013762-25-004299 |
| As of 2024-12-31 | 7538000 | USD | 2026-03-23 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001213900-26-032683 |
| As of 2025-12-31 | 11562000 | USD | 2026-03-23 | 2025 / FY | us-gaap:LiabilitiesCurrent | 10-K · 0001213900-26-032683 |
Stockholders equity
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| As of 2021-12-31 | -44960000 | USD | 2024-04-01 | 2023 / FY | us-gaap:StockholdersEquity | 10-K · 0001213900-24-028894 |
| As of 2022-12-31 | -36195000 | USD | 2025-03-31 | 2024 / FY | us-gaap:StockholdersEquity | 10-K · 0001013762-25-004299 |
| As of 2023-12-31 | -1776000 | USD | 2026-03-23 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001213900-26-032683 |
| As of 2024-12-31 | -18842000 | USD | 2026-03-23 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001213900-26-032683 |
| As of 2025-12-31 | -12158000 | USD | 2026-03-23 | 2025 / FY | us-gaap:StockholdersEquity | 10-K · 0001213900-26-032683 |
Revenue
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2022-01-01 to 2022-12-31 | 237000 | USD | 2024-04-01 | 2023 / FY | us-gaap:Revenues | 10-K · 0001213900-24-028894 |
| 2023-01-01 to 2023-12-31 | 316000 | USD | 2025-03-31 | 2024 / FY | us-gaap:Revenues | 10-K · 0001013762-25-004299 |
| 2024-01-01 to 2024-12-31 | 225000 | USD | 2026-03-23 | 2025 / FY | us-gaap:Revenues | 10-K · 0001213900-26-032683 |
| 2025-01-01 to 2025-12-31 | 241000 | USD | 2026-03-23 | 2025 / FY | us-gaap:Revenues | 10-K · 0001213900-26-032683 |
Cost of revenue
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2022-01-01 to 2022-12-31 | 498000 | USD | 2024-04-01 | 2023 / FY | us-gaap:CostOfGoodsAndServicesSold | 10-K · 0001213900-24-028894 |
| 2023-01-01 to 2023-12-31 | 789000 | USD | 2025-03-31 | 2024 / FY | us-gaap:CostOfGoodsAndServicesSold | 10-K · 0001013762-25-004299 |
| 2024-01-01 to 2024-12-31 | 742000 | USD | 2026-03-23 | 2025 / FY | us-gaap:CostOfGoodsAndServicesSold | 10-K · 0001213900-26-032683 |
| 2025-01-01 to 2025-12-31 | 874000 | USD | 2026-03-23 | 2025 / FY | us-gaap:CostOfGoodsAndServicesSold | 10-K · 0001213900-26-032683 |
Research and development
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2022-01-01 to 2022-12-31 | 4975000 | USD | 2024-04-01 | 2023 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001213900-24-028894 |
| 2023-01-01 to 2023-12-31 | 8956000 | USD | 2025-03-31 | 2024 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001013762-25-004299 |
| 2024-01-01 to 2024-12-31 | 10179000 | USD | 2026-03-23 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001213900-26-032683 |
| 2025-01-01 to 2025-12-31 | 12486000 | USD | 2026-03-23 | 2025 / FY | us-gaap:ResearchAndDevelopmentExpense | 10-K · 0001213900-26-032683 |
Operating income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -5204970 | USD | 2023-04-03 | 2022 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001104659-23-040842 |
| 2022-01-01 to 2022-12-31 | -8706000 | USD | 2024-04-01 | 2023 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001213900-24-028894 |
| 2023-01-01 to 2023-12-31 | -18359000 | USD | 2025-03-31 | 2024 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001013762-25-004299 |
| 2024-01-01 to 2024-12-31 | -19256000 | USD | 2026-03-23 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001213900-26-032683 |
| 2025-01-01 to 2025-12-31 | -22270000 | USD | 2026-03-23 | 2025 / FY | us-gaap:OperatingIncomeLoss | 10-K · 0001213900-26-032683 |
Net income
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -251633 | USD | 2023-04-03 | 2022 / FY | us-gaap:NetIncomeLoss | 10-K · 0001104659-23-040842 |
| 2022-01-01 to 2022-12-31 | -15923000 | USD | 2024-04-01 | 2023 / FY | us-gaap:NetIncomeLoss | 10-K · 0001213900-24-028894 |
| 2023-01-01 to 2023-12-31 | -29922000 | USD | 2025-03-31 | 2024 / FY | us-gaap:NetIncomeLoss | 10-K · 0001013762-25-004299 |
| 2024-01-01 to 2024-12-31 | -20795000 | USD | 2026-03-23 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001213900-26-032683 |
| 2025-01-01 to 2025-12-31 | -23756000 | USD | 2026-03-23 | 2025 / FY | us-gaap:NetIncomeLoss | 10-K · 0001213900-26-032683 |
Diluted earnings per share
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2022-01-01 to 2022-12-31 | -1.57 | USD/shares | 2024-04-01 | 2023 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001213900-24-028894 |
| 2023-01-01 to 2023-12-31 | -2.54 | USD/shares | 2025-03-31 | 2024 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001013762-25-004299 |
| 2024-01-01 to 2024-12-31 | -1.49 | USD/shares | 2026-03-23 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001213900-26-032683 |
| 2025-01-01 to 2025-12-31 | -1.23 | USD/shares | 2026-03-23 | 2025 / FY | us-gaap:EarningsPerShareDiluted | 10-K · 0001213900-26-032683 |
Operating cash flow
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2021-01-01 to 2021-12-31 | -3240821 | USD | 2023-04-03 | 2022 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001104659-23-040842 |
| 2022-01-01 to 2022-12-31 | -8805000 | USD | 2024-04-01 | 2023 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001213900-24-028894 |
| 2023-01-01 to 2023-12-31 | -17091000 | USD | 2025-03-31 | 2024 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001013762-25-004299 |
| 2024-01-01 to 2024-12-31 | -17949000 | USD | 2026-03-23 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001213900-26-032683 |
| 2025-01-01 to 2025-12-31 | -18201000 | USD | 2026-03-23 | 2025 / FY | us-gaap:NetCashProvidedByUsedInOperatingActivities | 10-K · 0001213900-26-032683 |
Capital expenditure
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2022-01-01 to 2022-12-31 | 218000 | USD | 2024-04-01 | 2023 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001213900-24-028894 |
| 2023-01-01 to 2023-12-31 | 153000 | USD | 2025-03-31 | 2024 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001013762-25-004299 |
| 2024-01-01 to 2024-12-31 | 980000 | USD | 2026-03-23 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001213900-26-032683 |
| 2025-01-01 to 2025-12-31 | 179000 | USD | 2026-03-23 | 2025 / FY | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment | 10-K · 0001213900-26-032683 |
Dividends paid
| Reported period | Value | Unit | Filed | Filing FY / FP | Taxonomy concept | Source filing |
|---|---|---|---|---|---|---|
| 2024-01-01 to 2024-12-31 | 2447000 | USD | 2026-03-23 | 2025 / FY | us-gaap:PaymentsOfDividends | 10-K · 0001213900-26-032683 |
| 2025-01-01 to 2025-12-31 | 1819000 | USD | 2026-03-23 | 2025 / FY | us-gaap:PaymentsOfDividends | 10-K · 0001213900-26-032683 |
Source and method
SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.
The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.
- Source filer CIK
- 1840877
- Ticker in native snapshot
- COCH
- Reported numeric facts
- 75
- Units present
- USD · USD/shares